Furthermore, the elevated expression of BHLHE40 was correlated with hypoxia activation, increased metastatic potential, and poor prognosis of various cancer types including hepatocellular carcinoma, pancreatic cancer, and invasive breast cancer36–38. The gene discussed is BHLHE40; the disease is hepatocellular carcinoma.